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Purpose of review: Impaired reward processing and amotivation are well documented in schizophrenia. 
We aim to review the current state of neuroimaging and behavioral research addressing components of 
motivational deficits in this complex and impairing syndrome. Evidence will be integrated to inform the 
ongoing development of effective strategies for behavioral rehabilitation. Recent findings: While striatal 
dopamine and aberrant reward prediction errors have been connected to amotivation in schizophrenia, 
they are not sufficiently full explanations of reward processing impairments. Frontal dysfunction and 
associated cognitive control deficits also have evidenced involvement in atypical reward prediction, 
learning, and valuation. Ongoing work supports the utility of interventions (e.g., cognitive remediation) 
for improved motivation for rewards. Summary: Within schizophrenia, greater negative symptoms 
(avolition and anhedonia) are associated with poorer functioning and more severely impaired reward 
processing. Utilizing behavioral interventions such as cognitive remediation and social cognition training 
hold promise for rehabilitation and increased community integration. 
 























Impairments in motivation, associated with deficits in reward processing, are supported as a 
central component of schizophrenia (SZ) [1]. Reduced motivation and goal-oriented behavior is a main 
component of negative symptoms, which are associated with treatment-resistant functional impairment in 
people with schizophrenia (PSZ) [2-5]. Evidence concerning the latent structure of negative symptoms 
supports five core domains: anhedonia, avolition, asociality, blunted affect, and alogia [6]. Additional 
evidence of a higher-order dimension—motivation and pleasure (MAP)—which influences anhedonia and 
avolition suggests possible pathophysiological links between the two negative symptom dimensions [6]. 
Avolition and anhedonia are associated with reward processing deficits. Focusing on diminished 
expressivity (e.g., blunted affect, alogia) has been evidenced as comparatively less critical in recovery 
models [2,7]. Research supports deficits in the anticipation of pleasure, rather than the capacity to 
experience pleasure, as a factor underlying motivational impairment in PSZ [2,8-10]. While treating 
motivational abnormalities in PSZ has been evidenced to benefit functional outcomes, neural and 
behavioral mechanisms underlying these deficits have yet to be fully understood [11].  
 The construct of motivation is complex, incorporating direction (i.e., approach-avoidance) and 
degree of energy (i.e., persistence and vigor) in relation to the initiation (or absence) of goal-directed 
behavior [1]. Motivation to engage in or refrain from activity is related to the experience of salient 
rewards and aversive events. Heuristic models of motivation connect anticipated and experienced rewards 
with generated and maintained plans for action that are necessary to receive rewards [12]. Associations 
among rewarding stimuli, actions, and outcomes must be learned (i.e., reward learning) for behavior to be 
initiated. Additionally, the perceived degree of effort needed to attain rewards influences motivation to 
act.  
        The Research Domain Criteria Initiative (RDoC) includes a “positive valence” systems domain, 
encompassing constructs underlying impairments in motivation and hedonic capacity across 
psychopathology [11,13]. The positive valence systems domain includes reward responsiveness, reward 
learning, and reward valuation [13]. Table 1 details components of the positive valence systems domain, 
along with associated brain regions and behavioral assessments utilized to capture performance relative to 
these constructs. Aberrant functioning in SZ has been evidenced across reward processing constructs [11]. 
Additionally, evidence supports the presence of impairment in reward processing and motivation in PSZ 
across incentive types (e.g., money, food) [14,15]. 
Herein, recent neuroimaging and behavioral research focused on elucidating reward processing 
impairments in PSZ will be reviewed. Research examining positive valence systems constructs will be 
emphasized. Better understanding of the mechanisms underlying reward processing and motivation 
deficits can inform the composition of evidence-based intervention strategies for behavioral rehabilitation 
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that hold promise for the improvement of daily functioning for PSZ. As the association between 
amotivation and impaired functioning in PSZ is well established [16], focus placed on translating 
evidence for mechanisms underlying reward processing deficits to inform behavioral rehabilitation could 
greatly improve the lives of PSZ.  
Neural Underpinnings of Reward and Motivation in Schizophrenia 
         The frontal-striatal network has an evidenced role in reward processing, motivation, and 
associated deficits [17]. Brain regions implicated in reward processing deficits include the anterior 
cingulate cortex (ACC), dorsolateral prefrontal cortex (dlPFC), ventrolateral prefrontal cortex (vlPFC), 
orbitofrontal cortex (OFC), basal ganglia (BG), and caudate nucleus [11,18]. Basic neuroscience supports 
the existence of two complimentary neural systems that underlie reward processing and utilize reward 
prediction errors (RPEs) in doing so [2,19]. One such system underlies gradual reinforcement learning is 
mediated by the BG. Another system involves the updating of mental reward representations and 
associated possible responses relative to reinforcement contingencies. This system underlies rapid 
learning and is mediated by the PFC (specifically, the OFC). The dlPFC has been connected to the 
generation and completion of goal-directed behavior in effort to receive rewards.  
An association between reward processing deficits in SZ and dysfunctional signaling of dopamine 
(DA) has been well documented [20]. DA neurons calculate RPEs themselves, playing an active role in 
assessing the difference between reward that is expected and reward that is received [21]. Typically, 
increases in DA are associated with positive RPEs (i.e., indicating better-than-expected outcomes), and 
decreases in DA are associated with negative RPEs (i.e., indicating worse-than-expected outcomes) [2]. 
DA neurons in the midbrain [e.g., substantia nigra, ventral tegmental area (VTA)] that project to the 
ventral- and dorsal-striatum mediate reward prediction as well as implicit reinforcement learning [11,22]. 
Explicit reinforcement learning, involving value representations and cognitive control, has been 
associated with the OFC and the parietal and dorsal-frontal cortices [11]. Reward valuation (including 
cost/benefit analyses of rewards) involves the dorsal ACC (dACC) and DA activity in the nucleus 
accumbens. A non-clinical investigation evidenced a positive association between midbrain D2 receptor 
availability and neural activity in the left ventral-striatum during a reward valuation task [23]. In a recent 
longitudinal investigation, first-episode PSZ determined to be treatment responders evidenced a 
correlation between BOLD signal improvement in the caudate nucleus captured during reward 
anticipation and D2 receptor occupancy, suggesting that symptom reduction relates to improvement of 
reward system abnormalities via antipsychotics [24].   
While much research on reward processing has focused on DA, the influence of a range 
neuropeptides is being explored. Gamma-aminobutyric acid (GABA) and opioid signaling have also been 
implicated in reward processing and associated deficits [25,26]. Additionally, support for the role of 
LEARNING AND MOTIVATION FOR REWARDS IN SCHIZOPHRENIA 5 
 
 
oxytocin in increasing motivation for social reward in PSZ has been evidenced [27]. Though, an 
investigation of the effects of oxytocin on vigor (i.e., motivation intensity) in PSZ did not find a 
significant association between oxytocin and increased vigor during social encouragement [28].   
Recent Updates in Neuroscience and Behavioral Research 
Building off of identified neural circuitry underlying reward processing and motivation, ongoing 
research adds to our understanding of these systems and how they are impaired in SZ. As the literature on 
reward processing in SZ is vast, details of research conducted throughout the past five years are 
highlighted.  
Overall Reward Processes 
The negative symptom dimension of MAP (alternatively referred to as “apathy”) has been 
differentiated from diminished expressivity and has been differentially associated with functional 
impairment. Additionally, research points to different neural mechanisms underlying these dimensions 
[7]. As striatal dysfunction is proposed to underly negative symptoms, a recent investigation examined 
resting-state cerebral blood flow (rCBF) in the striatum of PSZ. Severity of apathy, but not diminished 
expressivity, was found to be associated with increased rCBF in the ventral- and dorsal-striatum [7]. 
However, overall rCBF in the ventral- and dorsal-striatum was not found to significantly differ between 
PSZ and controls. Despite the evidenced association between apathy and striatal hypoactivation, the 
relationship between reduced striatal volume and apathy is less clear [4].  
 It is important to identify how components of reward processing function in at-risk populations. 
A recent fMRI examination evidenced no significant brain activation differences between clinical high 
risk (CHR) youth and controls during reward anticipation and receipt, suggesting motivation for reward 
may be spared at this stage [29]. However, CHR youth evidenced reward learning impairments and 
exhibited blunted RPE signals in the ventral-striatum, dACC, and ventromedial-PFC (vmPFC). Another 
study examining psychotic like experiences (PLEs) in a university sample evidenced a significant 
association between higher PLEs and greater effort expenditure regardless of reward probability and 
value, suggesting that hypersensitivity to reward may be present in less severe presentations of the 
psychotic continuum [30]. 
Reward Anticipation/Prediction 
 Anticipation or prediction of reward refers to the “wanting” component of reward processing (i.e., 
anticipatory pleasure). Reduced activity in the ventral-striatal network of PSZ has been evidenced relative 
to reward-predictive cues [11,31]. This reduction in ventral-striatal activity has been found in both 
medicated and unmedicated PSZ; though, some research suggests that these deficits are not seen in 
patients on atypical antipsychotics and those in the prodrome [32,33]. Mechanisms underlying deficits in 
reward anticipation may extend beyond ventral striatal DA, implicating cognitive control mechanisms 
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such as representation and maintenance of reward and working memory [34,35]. A recent meta-analysis 
of fMRI studies examining appetitive anticipation signals revealed significant reduction in activation 
within the frontal-striatal network in PSZ compared to controls [36]. Notably, reduced activation was 
evidenced in the cingulate/paracingulate gyri and left-striatum of PSZ, extending reward anticipation 
deficits beyond the ventral-striatum. These findings remained significant when controlling for psychotic 
symptom severity and antipsychotics. An examination of reward representation activation and 
maintenance in PSZ was conducted in effort to assess mechanisms underlying anticipatory anhedonia 
[37]. When anticipating rewards with high probability in situations wherein representation activation and 
maintenance were difficult to achieve, PSZ exhibited lower subjective arousal compared to controls, 
possibly accounting for anticipatory anhedonia. Another investigation evidenced attenuated anticipatory, 
but not consummatory, pleasure for rewards in PSZ but not in people with high schizotypy [8]. This 
suggests that differences between anticipatory and consummatory pleasure may, in part, account for the 
anhedonia/emotion paradox in SZ. 
  Reduced activity in the ACC and insula in PSZ has also been evidenced during prediction of 
reward [38,39]. Recent findings suggest that antipsychotics may normalize connectivity between the ACC 
and insula evident during reward prediction [40]. In a study of reward anticipation deficits relative to 
incentive type, PSZ evidenced increased reaction times compared to controls related to both monetary and 
social stimuli [41]. Though, PSZ exhibited improved performance relative to reward increases, suggesting 
that patients who are treated with atypical antipsychotics may have capacity to anticipate monetary and 
social awards which could be leveraged in intervention strategies. 
Initial Response to Reward/Reward Receipt 
 Hypoactivation of the medial-frontal-cortex and ACC has been evidenced during expected reward 
receipt in PSZ [42]. Though, some evidence points to reward receipts being spared in motivational 
deficits [43]. Notably, this research has focused on predictable rewards. In a cross-diagnostic examination 
of unexpected reward receipt, reduced activation compared to controls was evidenced in the OFC, 
ventral-striatum, inferior-temporal gyrus, and occipital cortex in both SZ and depression [44]. Greater 
hypoactivation of the medial-PFC relative to receipt of unexpected reward was evidenced in PSZ. PSZ, 
but not depression, showed abnormal activation in the lateral parietal cortex. As these regions have been 
connected to the signaling of surprising outcomes and are mediated by DA, it is notable that dysfunction 
was evidenced in SZ but not depression [45,46]. 
Reward Learning & Reward Prediction Errors 
 Reward anticipation is theorized to be an underlying component of implicit and explicit reward 
(or reinforcement) learning [11,47,48]. Aberrations in reward learning mechanisms have been associated 
with abnormal RPEs [21]. Figure 1 offers a theoretical depiction of reward learning and RPEs. 
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Reinforcement learning, involving integration of information regarding the probability of rewards and 
punishments, is mediated by dopaminergic projections in the midbrain to the dorsal and ventral BG 
[11,49]. The strength of DA response to rewards has been connected to reward predictability. Typically, 
rewards received that are unexpected or greater than predicted are associated with greater DA firing (i.e., 
positive RPE) and the reduction or absence of predicted rewards is associated with reduced DA firing 
(i.e., negative RPE) [19,22,50]. RPEs in SZ have been associated with bidirectionally altered DA activity 
in the ventral- and dorsal-striatum [11,51,52]. Negative associations have been evidenced between RPE 
magnitude in the BG and clinical symptoms (i.e., avolition) [53]. It has been suggested that first-
generation antipsychotics may reduce RPE responses [32]. Though, RPE reduction has also been 
evidenced in unmedicated PSZ [51,52]. Recent evidence suggests that RPE signaling during 
reinforcement learning is intact in medicated PSZ, despite worse task performance compared to controls 
[54,55]. 
While much research evidences reinforcement learning deficits in PSZ [56,57], some have not 
found such associations. A recent examination differentiating deficits related to causal (action-outcome) 
learning and reinforcement learning evidenced insensitivity to reward-value in PSZ but did not evidence 
reinforcement learning deficits [58]. Additionally, evidence supports relatively intact reinforcement 
learning in PSZ during simple and implicit learning tasks [59]. This pattern of findings suggests that 
striatal DA deficits cannot sufficiently explain impairments in reward prediction. Beyond dopaminergic 
explanations, cognitive control has been implicated in explicit learning and reward representation 
impairments [48]. PSZ evidence deficits in explicit reinforcement learning during more complex tasks 
involving sustained representations of rewards [60,61]. Impairment in explicit reinforcement learning has 
been associated with greater negative symptoms [59]. Working memory impairments in PSZ may 
contribute to explicit reinforcement learning deficits requiring representations of stimuli-reward 
relationships [59,62].  A protocol designed to identify separate contributions of working memory and 
reinforcement learning on performance in medicated PSZ evidenced that impairments in learning were 
associated with working memory deficits, while reinforcement learning was spared [63].  
It has been suggested that deficits in reinforcement learning are not specifically associated with 
RPE signaling, but rather the impact of RPE signaling on learning and behavior (i.e., learning rate 
modulation) due to dysfunction in the ACC and dorsomedial PFC (dmPFC) [54]. An investigation 
utilizing a probabilistic learning paradigm with shifting contingencies evidenced an association between 
learning rate modulation and decreased connectivity between the ventral-striatum and dmPFC. This 
relationship was stronger in PSZ with more severe motivational deficits. This suggests that impaired 
learning rate modulation could reduce one’s capacity to alter task-relevant behavior when met with 
unexpected outcomes.  
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 Evidence suggests that PSZ are worse at learning to predict rewards than learning to avoid losses 
and have reduced capacity to alter behavior in response to rewards [48,56,64-66]. However, some 
investigations have not evidenced this pattern [59]. Notably, research concerning response to rewards and 
losses has largely been conducted with medicated patients, and it has been argued that this differential 
performance relative to reward prediction and loss avoidance could be influenced by the effects of D2 
receptor blockades. To assess learning of rewards and losses in PSZ without the potential confound of 
antipsychotics, an fMRI comparison of unmedicated PSZ and controls utilized a probabilistic learning 
task [67]. PSZ evidenced attenuated RPE response in regions including the striatum, medial temporal 
lobe, and medial PFC when learning to predict rewards but not when learning to avoid losses, suggesting 
that motivational context (reward vs. loss avoidance) modulates RPE response independent of medication 
effects. As many PSZ exhibit treatment refractory symptoms, mechanistic explanations beyond the effects 
of DA are suggested to underlie symptoms of SZ and associated deficits. In a fMRI comparison of 
treatment-refractory and non-refractory PSZ, reinforcement learning impairment was evidenced in both 
groups relative to controls [68]. Though, treatment-refractory and non-refractory PSZ may differ in 
patterns of neural mechanisms underlying reinforcement learning, with antipsychotic response related to 
initial DA dysfunction and treatment resistance related to dysfunction in other neurotransmitters (e.g., 
glutamate). Another fMRI investigation evidenced reduced learning from positive feedback by PSZ [57]. 
Though, reduced learning from positive feedback was not related to severity of anhedonia and avolition, 
and RPE activation was similar between PSZ and controls during task feedback. PSZ did evidence lesser 
cognitive control network activation during early learning compared to controls. PSZ with greater 
avolition and anhedonia exhibited reduced response in the dlPFC and caudate relative to positive 
feedback. This suggests that anhedonia and avolition are related to deficits in higher-level cortical 
learning and reduced cognitive control. 
 As studies have examined potential differences among incentive types in reward anticipation, 
others have assessed different incentive types in reward learning. An examination of social and non-social 
reward learning evidenced impairments relative to each incentive type in both PSZ and their first-degree 
relatives but not in controls [15]. This suggests that PSZ and their first-degree relatives experience a 
general reduction in reward sensitivity reflective of familial vulnerability rather than illness process.  
Reward Valuation 
Reward valuation refers to assessing the benefits and probability of possible reward outcomes 
(i.e., effort-cost computation), which includes the activation and maintenance of reward representation, 
implicating working memory [69]. Reward valuation impairment in PSZ has been evidenced across 
incentive types [37,70,71]. Investigations utilizing measures that require participants to update 
representations of rewards and punishments (i.e., value representations), such as the Iowa Gambling Task 
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(IGT), have evidenced impaired performance by PSZ [72]. A meta-analysis comparing performance on 
the IGT by PSZ and controls evidenced decision-making impairments in PSZ characterized by an 
underweighting of gain frequency and overweighting of net losses and immediate gains [73]. Impairments 
in cognitive control and representation of goals have been documented in PSZ and associated with 
abnormal activation in the dlPFC [11,17,48,74]. The lateral and medial OFC are also theorized to underlie 
value computations involving updating reinforcement contingencies [11,48]. Though, evidence 
supporting the role of the OFC in reward valuation impairment is wanting. In animal research, projections 
from the ventrolateral OFC to the basolateral amygdala have been found to be critical for encoding 
positive reward-value, and projections from the medial OFC to the basolateral amygdala have been found 
to be critical for value retrieval [75]. FMRI research has supported the importance of the cingulo-striatal 
network in amotivation and has evidenced the focal role of the ACC in translating the value of an action 
to its initiation [76]. Clinically stable PSZ evidenced reduced activation in the rostro-ventral ACC, in 
addition to altered striatal activity, during initiation of approach to reward. Reduced sensitivity to value-
changes in guiding decisions in PSZ has also been associated with greater self-reported aberrant salience 
traits, suggesting that altered reward processing closely relates to aberrantly salient attributions in SZ 
[77]. 
 It has been proposed that PSZ experience difficulty in integrating the probability and magnitude 
of experienced outcomes when assessing reward-value. In an investigation examining mechanisms 
underlying deficits in probability-magnitude integration in PSZ, a learning paradigm was utilized wherein 
variations in reward-magnitude and probability established the expected value (EV) of each stimulus [78]. 
PSZ with motivational deficits did not accurately represent reward-magnitude, relying heavily on 
stimulus-response associations that were void of value rather than utilizing EV-based learning.  
Effort-Allocation & Goal-Directed Decision Making 
PSZ evidence difficulty with integrating causal knowledge regarding changes in outcome values 
to guide decisions [79]. Additionally, an expanding body of research shows that PSZ exhibit less 
willingness to expend effort to receive rewards compared to controls, and much work exhibits 
associations among impaired effort-allocation, greater negative symptoms, and poorer functioning 
[80,81]. Many investigations focused on effort-allocation in reward processing have utilized paradigms 
requiring physical effort expenditure (e.g., grip strength) [82,83]. PSZ exhibit reduced allocation of 
physical effort relative to increases in reward-value or probability [11,82-84]. Preliminary research on 
allocation of cognitive effort suggests that cognitive effort may be reduced in PSZ; though, potential 
confounding effects of physical effort need to be better accounted for [85]. Deficits in motivation for 
physical effort expenditure have recently been evidenced to significantly correlate with reduced global 
cognition, as well as reduced attention and processing speed [86].  
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A recent examination of self-efficacy relative to effort-cost computation revealed associations 
among greater low-effort choices, greater negative symptoms, greater working memory deficits, poor 
self-efficacy, and reduced anticipatory pleasure [87]. Deficits in effort allocation were associated with 
greater impairment in completing skills of daily functioning. Evidenced trouble with effective effort 
allocation experienced by PSZ exhibiting greater negative symptoms could relate to the formation of 
negative beliefs about competency, further contributing to amotivation. 
Implications for Behavioral Rehabilitation Treatment Strategies 
 It is important to utilize what is known regarding the mechanisms underlying impaired motivation 
for rewards to establish effective forms of behavioral rehabilitation that target these deficits. Addressing 
reward processing impairment in PSZ holds promise for improved symptoms, social engagement, and 
overall functioning. Table 2 depicts behavioral rehabilitation recommendations. As impaired cognitive 
control has been implicated in explicit learning deficits in PSZ, cognitive remediation interventions have 
been examined and have evidenced improvement in reward processing and negative symptoms in SZ 
[88,89]. Cognitive remediation has also been associated with improvements in social functioning and 
negative symptoms in first-episode SZ [90]. A program designed to focus on improvement of cognitive 
skills and emotion regulation [Positive Emotions Programme for Schizophrenia (PEPS)] evidenced 
greater improvement in apathy and anhedonia scores for PSZ at post-treatment and follow-up compared 
to treatment as usual [91]. A real-world feasibility assessment of PEPS evidenced significant 
improvement of negative symptoms and social functioning post-treatment [92]. Cognitive training that 
integrates exercises aimed at improving social cognition hold promise for improving reward processing 
and daily functioning in PSZ [93]. The development of real-time interventions (e.g., mobile applications) 
may also be of benefit, particularly for at-risk and first-episode populations [94]. Psychopharmacological 
intervention, particularly with atypical antipsychotics, has been associated with improvement in reward 
system abnormalities and can augment positive results of cognitive training via the maintenance of 
clinical stability [24]. Notably, examination of first-generation antipsychotic treatment has not evidenced 
these same improvements [32]. Additionally, anticholinergic treatment has been associated with memory 
impairments in PSZ and can constrain the potential benefits of cognitive training and psychosocial 
interventions [95].  
 Evidence supports the utility of incorporating extrinsic rewards in promoting volitional extrinsic 
motivation in PSZ [49,96]. Patients with low intrinsic motivation, common in SZ, have been evidenced to 
benefit more from such interventions compared to patients with greater intrinsic motivation [49]. Low-
baseline intrinsic motivation may itself be improved in PSZ; a recent examination of intrinsic motivation 
in SZ found that during the completion of cognitive games, PSZ who received informationally 
administered rewards (i.e., positive feedback) reported and evidenced greater intrinsic motivation than 
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patients in a no-feedback condition [97]. Saperstein and Medalia detail components of self-determination 
theory (SDT) as determinants of the development of intrinsic motivation to attain rewards [98]. Through 
the lens of SDT, it is recommended that interventions (e.g., cognitive remediation) are personalized 
according to individuals’ recovery goals, incorporate opportunities for patients to exercise choice 
(fostering autonomy and competency), and provide for contextualization of learning to practical, everyday 
circumstances.  
The Second Chance program at the Westchester Division of New York Presbyterian Hospital is 
an inpatient rehabilitation unit which serves as an example of a program utilizing a social learning 
framework which incorporates the provision of extrinsic rewards in effort to improve intrinsic motivation 
and functional impairment in treatment-resistant PSZ [99,100]. Second Chance utilizes a token economy 
aimed at the acquisition and improvement of skills of independent living within a collaborative-
supportive framework wherein patients’ perceived competency is fostered by the treatment team. The 
attainment of immediate rewards (e.g., milieu-based positive feedback, tickets that can be traded in for 
prizes) serve as reminders for the ability to meet overarching, distal goals (e.g., time spent off the unit). 
This is of benefit as PSZ evidence deficits in orienting toward long-term rewards [101].  
 Integrating what is known regarding impairments in motivation and reward processing in PSZ 
with preliminary evidence regarding behavioral rehabilitation, recommendations for treatment strategies 
are as follows:  
1. Disseminate cognitive remediation targeting working memory impairment as this has 
been associated with improvements in negative symptoms and social functioning, and  
personalize training to individual patients’ needs. Additionally, provide cognitive 
supports and training for the use of compensatory cognitive strategies. Gains in ability to 
maintain reward value representations may underlie the connection between cognitive 
training and reward processing improvement.  
2. Establish a token economy wherein extrinsic rewards are provided for adaptive 
behaviors.  
3. Provide rewards in real-time with consistency and clarity. 
4. Utilize a collaborative-supportive orientation, reinforcing the development of 
competency and intrinsic motivation. 
5. Incorporate social cognition and emotion regulation training in group and individual 
psychotherapy for PSZ. 
6. Foster the development and examination of real-time intervention strategies (e.g., mobile 
applications) aimed at improving cognition and motivation in at-risk and early-illness 
populations. 
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7. Implement behavioral rehabilitation for the improvement of motivation in tandem with 
pharmacological treatment as usual.  
Conclusions 
  Reward processing deficits are common in SZ and are associated with greater negative 
symptoms, particularly avolition and anhedonia. Dysfunctional dopaminergic signaling in the striatum, 
underlying aberrant reward prediction errors, is associated with amotivation. Additionally, the frontal-
striatal network and impaired cognitive control have been associated with altered reward prediction 
(anticipatory pleasure), reward receipt, explicit reward learning, and reward valuation as PSZ evidence 
difficulty with activating and maintaining mental representations of rewards. As apathy and aberrant 
reward processing are associated with greater functional impairment and poorer quality of life for PSZ, 
incorporating behavioral rehabilitation strategies tailored to the improvement of these deficits stands to 
greatly improve illness course and daily living. Cognitive remediation, social cognition, and emotion 
regulation training should be incorporated in treatment protocols for PSZ with low intrinsic motivation 
and greater avolition and anhedonia. Additionally, utilizing a social learning framework wherein 
consistent extrinsic rewards are provided for adaptive behaviors within a supportive and collaborative 
environment holds promise for the development of motivational and reward processing gains in SZ. 
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1. Personalized cognitive remediation training 
2. Utilization of social learning theory and token economy 
3. Clarity and consistency in reward provision 
4. Collaborative-supportive treatment orientation 
5. Incorporation of social cognition and emotion regulation training 
6. Development of real-time interventions 
7. Concurrent continuation of standard treatment (e.g., antipsychotics, CBT) 
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